Un collectif pour GAGNER du temps & de l'argent
1:15
Un collectif pour GAGNER du temps & de l'argent
10 views4 months ago
YouTubeBaresto
PIO - C'est comme ça (feat. Theya) (Visualizer)
2:57
PIO - C'est comme ça (feat. Theya) (Visualizer)
153 views3 weeks ago
YouTubePIO
Can PSMA PET Parameters Help Predict Toxicity and Outcomes in Patients Treated for mCRPC? | Diagnostic Imaging
Can PSMA PET Parameters Help Predict Toxicity and Outcomes in …
1 month ago
diagnosticimaging.com
Wie vernetze ich meinen Scout mit der Miele Scout App und mit Amazon Alexa? | Miele
2:25
Wie vernetze ich meinen Scout mit der Miele Scout App und mit Amaz…
506 viewsJan 30, 2023
YouTubeMiele Service
مسجد وزیر خان – تاج محل کے بعد شاہجہان کا دوسرا عجوبہ
0:24
مسجد وزیر خان – تاج محل کے بعد شاہجہان کا دوسرا عجوبہ
1.1K views5 months ago
YouTubeSocialTVChannel101
This VISION Trial Secondary Analysis: 177Lu-PSMA-617 With Concomitant ARPIs vs. SoC in mCRPC
This VISION Trial Secondary Analysis: 177Lu-PSMA-617 With C…
114 views11 months ago
vumedi.com
The VISION Study of 177Lu-PSMA-617 in mCRPC | OncLive
The VISION Study of 177Lu-PSMA-617 in mCRPC | OncLive
3 weeks ago
onclive.com
ASCO® 2025 Insights: Liquid Biopsy Approaches to Detect PSMA and 1…
99 views8 months ago
vumedi.com
Treatment Sequencing in mCRPC: Evidence From VISION, TheraP, a…
154 views9 months ago
vumedi.com
VISION Trial: Novel PSMA-Targeted Radiotherapy Improves Outcome…
Jul 26, 2021
ascopost.com
FDA Approval of 177Lu-PSMA-617 for Taxane-Naive mCRPC - Oliver …
11 months ago
urotoday.com
Potential Role of Lu-PSMA-617 in mCRPC | OncLive
1 week ago
onclive.com
Use of PSMA PET Scans in Advanced Prostate Cancer | OncLi…
Jul 30, 2021
onclive.com
Dr. Gafita on Sequencing 177Lu-PSMA-617 in mCRPC | OncLive
3 weeks ago
onclive.com
ESMO 2024 Insights: STAMPEDE2 Comparison P - Upfront Accelerat…
85 viewsSep 25, 2024
vumedi.com
Efficacy and Toxicity of 177Lu-PSMA-617 for mCRPC: Results Fr…
108 viewsNov 20, 2024
vumedi.com
ASCO® 2025 Insights: Robust Characterization of Response and …
38 views8 months ago
vumedi.com
ESMO 2025 Insights: 177Lu-PSMA-617 With ADT ARPI Improves rPF…
24 views3 months ago
vumedi.com
ASCO® GU 2025 Insights: mCRPC Survival Outcomes With 177Lu-PS…
147 viewsFeb 25, 2025
vumedi.com
PSMA-Targeted Radioligand Therapy in Advanced Prostate Ca…
Jul 30, 2021
onclive.com
Dr. Ravi on Ongoing Investigation of PSMA-targeted Therapies in mCR…
1 week ago
onclive.com
ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to …
1.8K viewsJun 8, 2023
vumedi.com
Expert Discusses When to Perform PSMA PET Imaging for Metastatic …
Aug 24, 2022
targetedonc.com
Dr. Parker on current role of FDA-approved PSMA-PET imaging age…
2K viewsSep 22, 2022
urologytimes.com
Lutetium-177 PSMA Therapy for Prostate Cancer (Pluvicto) - UChic…
Jun 17, 2022
uchicagomedicine.org
What is the Role of 177Lu-PSMA-617 in Metastatic CRPC? | OncLive
1 week ago
onclive.com
Dr. Morris on Logistical Challenges of Using 177Lu-PSMA-617 in Prost…
Jan 11, 2022
onclive.com
Dr. Morris on the Efficacy of 177Lu-PSMA-617 Plus Best SOC in mCR…
Aug 19, 2021
onclive.com
Dr. Tagawa on the Investigation of 225Ac-J591 and 177Lu-PSMA-I&T i…
1 week ago
onclive.com
VISION Study | Targeted Oncology - Immunotherapy, Biomarkers, and …
Oct 7, 2021
targetedonc.com
See more videos
Static thumbnail place holder